Insider Transactions in Q1 2025 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-3.18%
|
$216,030
$95.02 P/Share
|
|
Mar 12
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
7,500
-2.37%
|
$652,500
$88.0 P/Share
|
|
Mar 12
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.48%
|
$270,000
$36.05 P/Share
|
|
Mar 06
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,232
-7.63%
|
$455,184
$87.7 P/Share
|
|
Mar 05
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,766
-3.78%
|
$507,408
$88.8 P/Share
|
|
Mar 05
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,863
-12.0%
|
$427,944
$88.8 P/Share
|
|
Mar 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,326
-7.26%
|
$116,688
$88.8 P/Share
|
|
Mar 05
2025
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,284
-6.76%
|
$464,992
$88.8 P/Share
|
|
Mar 05
2025
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,733
-8.16%
|
$328,504
$88.8 P/Share
|
|
Mar 05
2025
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,262
-7.32%
|
$463,056
$88.8 P/Share
|
|
Mar 05
2025
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
6,489
-7.89%
|
$571,032
$88.8 P/Share
|
|
Mar 05
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,495
-8.32%
|
$571,560
$88.8 P/Share
|
|
Mar 05
2025
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
3,530
-5.84%
|
$310,640
$88.8 P/Share
|
|
Mar 05
2025
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
5,157
-9.42%
|
$453,816
$88.8 P/Share
|
|
Mar 05
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
16,151
-8.75%
|
$1,421,288
$88.8 P/Share
|
|
Mar 03
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,203
-3.17%
|
$294,676
$92.23 P/Share
|
|
Mar 01
2025
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+13.28%
|
-
|
|
Mar 01
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,506
+23.25%
|
-
|
|
Mar 01
2025
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+19.39%
|
-
|
|
Mar 01
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+21.35%
|
-
|
|
Mar 01
2025
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+16.73%
|
-
|
|
Mar 01
2025
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+13.83%
|
-
|
|
Mar 01
2025
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+12.33%
|
-
|
|
Mar 01
2025
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+15.41%
|
-
|
|
Mar 01
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+14.47%
|
-
|
|
Mar 01
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
35,200
+16.02%
|
-
|
|
Feb 20
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-3.39%
|
$216,030
$95.14 P/Share
|
|
Jan 21
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,446
-0.96%
|
$159,060
$110.24 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,161
-3.09%
|
$1,652,549
$109.88 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.63%
|
$360,000
$36.05 P/Share
|
|
Jan 21
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-0.83%
|
$250,140
$110.39 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$510,000
$102.28 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.98%
|
$180,000
$36.05 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-13.07%
|
$225,000
$100.0 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+11.56%
|
$81,000
$36.05 P/Share
|